Obesity:
Indications for Benzphetamine:
Short-term adjunct in management of exogenous obesity.
Adult:
≥17yrs: Individualized. Initially 25–50mg once daily in mid-morning or mid-afternoon. Increase if needed to 25–50mg 1–3 times daily.
Children:
<17yrs: not recommended.
Contraindications:
Advanced arteriosclerosis. Cardiovascular disease. Hypertension. Hyperthyroidism. Agitation. Drug or alcohol abuse. During or within 14 days of MAOIs. Pregnancy.
Warnings/Precautions:
Discontinue after a few weeks as tolerance to anorectic effect occurs. Diabetes. Prescribe limited supply to prevent overdose. Nursing mothers: not recommended.
Pharmacologic Class:
Sympathomimetic.
Interactions:
Hypertensive crisis with MAOIs. Blocks guanethidine. Altered insulin requirements. Potentiated by urinary alkalinizers. Antagonized by urinary acidifiers.
Adverse Reactions:
Abuse potential, impairment in hazardous activities, arrhythmias, hypertension, CNS overstimulation, psychosis, dry mouth, GI disturbances, urticaria, impotence.
Note:
Formerly known under the brand name Didrex.
How Supplied:
Contact supplier
